KIM AUSTIN D. 4
4 · ACADIA PHARMACEUTICALS INC · Filed Jan 9, 2024
Insider Transaction Report
Form 4
KIM AUSTIN D.
EVP AND GENERAL COUNSEL
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-01-06−1,634→ 0 total→ Common Stock (1,634 underlying) - Exercise/Conversion
Common Stock
2024-01-06+1,634→ 47,491 total - Sale
Common Stock
2024-01-08$29.96/sh−590$17,676→ 46,901 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.6641 to $29.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]The restricted stock units vest in four equal annual installments beginning January 6, 2021.